Google Orsiro, Its very similar to what BSX will have, THe stent won't completely absolve like the abt BVS yet its polymer is bioabsorbable, BEEV on the market in europe for 2 years. Very thin strut that will completely endotheliaze in 3 months with a rumored 3 month plavix indication.
Reason so many dismiss it? the ORIGINAL drug coating was a taxus like drug, in its first head to head with abt, abt had better outcomes. Now, Orsiro has the sirolimus drug, same drug that 90% of DES platforms have
Muchh info and excitement about this very flexible and deliverable stent. Abt BVS is getting all the press but my sources tell me "you cant see it and its not very flexible"- ouch........
Those are very important features on any stent, especailly to the pivate MD's who like to get case done quickly so they can get to the next one.
